Delta Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.9K | Hold |
430
| – | – | ﹤0.01% | 297 |
|
|
2025
Q4 | $38.7K | Hold |
430
| – | – | ﹤0.01% | 300 |
|
|
2025
Q3 | $42.4K | Hold |
430
| – | – | ﹤0.01% | 292 |
|
|
2025
Q2 | $39.2K | Sell |
430
-50
| -10% | -$4.83K | ﹤0.01% | 291 |
|
|
2025
Q1 | $54.3K | Hold |
480
| – | – | 0.01% | 253 |
|
|
2024
Q4 | $50.7K | Hold |
480
| – | – | ﹤0.01% | 264 |
|
|
2024
Q3 | $51.8K | Hold |
480
| – | – | ﹤0.01% | 264 |
|
|
2024
Q2 | $52.1K | Sell |
480
-160
| -25% | -$18.9K | ﹤0.01% | 258 |
|
|
2024
Q1 | $84.5K | Hold |
640
| – | – | 0.01% | 212 |
|
|
2023
Q4 | $77.9K | Hold |
640
| – | – | 0.01% | 218 |
|
|
2023
Q3 | $71.8K | Hold |
640
| – | – | 0.01% | 210 |
|
|
2023
Q2 | $93.2K | Hold |
640
| – | – | 0.01% | 195 |
|
|
2023
Q1 | $82.7K | Sell |
640
-64
| -9% | -$8.04K | 0.01% | 194 |
|
|
2022
Q4 | $89.8K | Buy |
+704
| New | +$81.7K | 0.01% | 179 |
|
|
2022
Q1 | – | Sell |
-825
| Closed | -$102K | – | 608 |
|
|
2021
Q4 | $102K | Hold |
825
| – | – | 0.01% | 179 |
|
|
2021
Q3 | $117K | Hold |
825
| – | – | 0.01% | 163 |
|
|
2021
Q2 | $129K | Buy |
825
+103
| +14% | +$16.7K | 0.01% | 152 |
|
|
2021
Q1 | $112K | Hold |
722
| – | – | 0.01% | 161 |
|
|
2020
Q4 | $108K | Buy |
722
+66
| +10% | +$9.32K | 0.01% | 156 |
|
|
2020
Q3 | $87K | Hold |
656
| – | – | 0.01% | 160 |
|
|
2020
Q2 | $76K | Hold |
656
| – | – | 0.01% | 170 |
|
|
2020
Q1 | $64K | Hold |
656
| – | – | 0.01% | 185 |
|
|
2019
Q4 | $95K | Buy |
656
+69
| +12% | +$9.52K | 0.01% | 176 |
|
|
2019
Q3 | $78K | Hold |
587
| – | – | 0.01% | 193 |
|
|
2019
Q2 | $67K | Hold |
587
| – | – | 0.01% | 200 |
|
|
2019
Q1 | $73K | Sell |
587
-155
| -21% | -$17.6K | 0.01% | 185 |
|
|
2018
Q4 | $75K | Hold |
742
| – | – | 0.01% | 182 |
|
|
2018
Q3 | $95K | Hold |
742
| – | – | 0.01% | 180 |
|
|
2018
Q2 | $80K | Hold |
742
| – | – | 0.01% | 186 |
|
|
2018
Q1 | $79K | Hold |
742
| – | – | 0.01% | 182 |
|
|
2017
Q4 | $87K | Hold |
742
| – | – | 0.01% | 179 |
|
|
2017
Q3 | $84K | Hold |
742
| – | – | 0.01% | 172 |
|
|
2017
Q2 | $92K | Hold |
742
| – | – | 0.01% | 164 |
|
|
2017
Q1 | $88K | Buy |
742
+11
| +2% | +$1.25K | 0.01% | 166 |
|
|
2016
Q4 | $73K | Hold |
731
| – | – | 0.01% | 188 |
|
|
2016
Q3 | $92K | Hold |
731
| – | – | 0.02% | 164 |
|
|
2016
Q2 | $85K | Hold |
731
| – | – | 0.01% | 173 |
|
|
2016
Q1 | $76K | Hold |
731
| – | – | 0.01% | 180 |
|
|
2015
Q4 | $73K | Hold |
731
| – | – | 0.01% | 192 |
|
|
2015
Q3 | $67K | Hold |
731
| – | – | 0.01% | 191 |
|
|
2015
Q2 | $78K | Hold |
731
| – | – | 0.01% | 188 |
|
|
2015
Q1 | $83K | Hold |
731
| – | – | 0.02% | 183 |
|
|
2014
Q4 | $81K | Hold |
731
| – | – | 0.02% | 177 |
|
|
2014
Q3 | $71K | Sell |
731
-52
| -7% | -$5.12K | 0.01% | 186 |
|
|
2014
Q2 | $79K | Hold |
783
| – | – | 0.02% | 180 |
|
|
2014
Q1 | $72K | Hold |
783
| – | – | 0.02% | 186 |
|
|
2013
Q4 | $71K | Sell |
783
-154
| -16% | -$13.3K | 0.02% | 185 |
|
|
2013
Q3 | $75K | Buy |
937
+51
| +6% | +$4.01K | 0.02% | 176 |
|
|
2013
Q2 | $64K | Buy |
+886
| New | +$66.2K | 0.02% | 185 |
|
Other funds holding ZBH
VCM
VPM
Delta Asset Management's ZBH Position: Q1 2026 in Review
Delta Asset Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 430 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #297.
Delta Asset Management first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $129K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Delta Asset Management held 430 shares of Zimmer Biomet worth $38.9K as of Q1 2026.
- Delta Asset Management left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Delta Asset Management's portfolio in Q1 2026, its #297 holding.
- Delta Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- Delta Asset Management's Zimmer Biomet position peaked at $129K in Q2 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.